Overall these results point to less suppressive Sparc−/− MDSC, endowed with cytostatic activities, and of the capacity of damaging tumor vasculature, thus explaining the reduced growth of tumor implanted into Sparc−/− mice. This evidence concerns the gene SPARC and neoplasm.